| Literature DB >> 34917503 |
Jikuan Jin1, Guangbing Xiong1, Xiaoxiang Wang1, Feng Peng1, Feng Zhu1, Min Wang1, Renyi Qin1.
Abstract
PURPOSE: The aim of this study was to investigate the effect of preoperative and postoperative malnutrition on postoperative short- and long-term outcomes for ampullary carcinoma after pancreatoduodenectomy (PD).Entities:
Keywords: Patient-Generated Subjective Global Assessment; ampullary carcinoma; malnutrition; pancreatoduodenectomy; postoperative outcomes
Year: 2021 PMID: 34917503 PMCID: PMC8669645 DOI: 10.3389/fonc.2021.748341
Source DB: PubMed Journal: Front Oncol ISSN: 2234-943X Impact factor: 6.244
Figure 1Flow diagram of before surgery and at 3, 6, and 12 months after pancreatoduodenectomy.
Clinicopathological characteristics of 511 patients who underwent pancreatoduodenectomy for ampullary carcinoma.
| Factors | Values |
|---|---|
| Age, years | 58 (49–66) |
| Sex (male) | 298 (58.3) |
| Body mass index, kg/m2 | 21.5 (19.9–23.5) |
| ASA class | |
| I | 75 (14.7) |
| II | 371 (72.6) |
| III | 65 (12.7) |
| Comorbidities | 124 (24.3) |
| Total bilirubin, μmol/L | 73.5 (18.6–163.9) |
| Albumin, mg/dl | 3.7 (3.3–3.9) |
| CA19-9, U/ml | 68 (18–220) |
| CA125, U/ml | 14.1 (9.7–22.5) |
| Estimated blood loss, ml | 200 (100–350) |
| Operative time, minutes | 275 (205–335) |
| T stage | |
| T1/T2 | 268 (52.4) |
| T3/T4 | 243 (47.6) |
| Lymph node metastasis, positive | 164 (32.1) |
| Vascular invasion, positive | 37 (7.2) |
| Perineural invasion | 51 (10.0) |
| Tumor grade | |
| Well or moderately | 414 (81.0) |
| Poorly | 97 (19.0) |
| Positive resection margin | 24 (4.7) |
| TNM stage | |
| I | 195 (38.2) |
| II | 136 (26.6) |
| III | 180 (35.2) |
| Adjuvant therapy | 218 (42.7) |
| Preoperative PG-SGA score | 8 (4–11) |
| 0–3 | 122 (23.9) |
| 4–8 | 189 (37.0) |
| >9 | 200 (39.1) |
| PG-SGA score after operation | |
| 3 months | 5 (3–6) |
| 6 months | 4 (3–6) |
| 12 months | 3 (2–9) |
Categorical variables were expressed as n (%); continuous variables are expressed as medians and interquartile ranges (IQR).
ASA, American Society of Anesthesiologists; CA19-9, carbohydrate antigen 19-9; CA125, carbohydrate antigen 125; PG-SGA, Patient-Generated Subjective Global Assessment.
Figure 2Changes in patients number in PG-SGA groups over time from before to 3, 6, and 12 months after pancreatoduodenectomy. A total of 122, 155, 199, and 245 patients were classified into well-nourished group (0–3 scores) before surgery and at 3, 6, and 12 months after operation, respectively; 189, 265, 207, and 78 patients were classified into moderately malnourished group (4–8 scores) before surgery and at 3, 6, and 12 months after operation, respectively; and 200, 67, 68, 116 patients were classified into severely malnourished group (>9 scores) before surgery and at 3, 6, and 12 months after operation, respectively.
The relationships between preoperative nutritional status and clinicopathological characteristics in 511 patients underwent pancreatoduodenectomy for ampullary carcinoma after PSM.
| Variables | Before PSM | After PSM | ||||
|---|---|---|---|---|---|---|
| Well-nourished/moderately malnourished | Severely malnourished | p-value | Well-nourished/moderately malnourished | Severely malnourished | p-value | |
| N = 311 | N = 200 | N = 200 | N = 200 | |||
| Age, years | 57 (50–64) | 59 (52–65) | 0.021 | 59 (51–64) | 59 (52–65) | 0.455 |
| Sex (male) | 181 (58.2) | 117 (58.5) | 0.946 | 118 (59.0) | 117 (58.5) | 0.919 |
| Body mass index, kg/m2 | 21.7 (19.9–23.8) | 21.8 (19.6–23.4) | 0.263 | 21.7 (19.9–23.7) | 21.8 (19.6–23.4) | 0.399 |
| ASA class | ||||||
| I/II | 274 (88.1) | 172 (86.0) | 0.486 | 173 (86.5) | 172 (86.0) | 0.885 |
| III | 37 (11.9) | 28 (14.0) | 27 (13.5) | 28 (14.0) | ||
| Comorbidities | 75 (24.1) | 49 (24.5) | 0.921 | 47 (23.5) | 49 (24.5) | 0.815 |
| Total bilirubin, μmol/L | 35.7 (14.0–92.9) | 164.7 (82.9–241.0) | <0.001 | 34.8 (14.5–94.3) | 164.7 (82.9–241.0) | 0.001 |
| CA19-9, U/ml | 48.3 (15.8–149.3) | 99.6 (32.4–576.8) | <0.001 | 78.1 (28.3–249.5) | 99.6 (32.4–576.8) | 0.114 |
| CA125, U/ml | 13.4 (9.1–20.0) | 16.0 (10.5–25.3) | 0.001 | 14.4 (9.0–19.0) | 16.0 (10.5–25.3) | 0.09 |
| T stage | ||||||
| T1/T2 | 174 (55.9) | 94 (47.0) | 0.048 | 100 (50.0) | 94 (47.0) | 0.548 |
| T3/T4 | 137 (44.1) | 106 (53.0) | 100 (50.0) | 106 (53.0) | ||
| Lymph node metastasis, positive | 87 (28.0) | 77 (38.5) | 0.013 | 71 (35.5) | 77 (38.5) | 0.534 |
| Vascular invasion | 18 (5.8) | 19 (9.5) | 0.114 | 12 (6.0) | 19 (9.5) | 0.191 |
| Perineural invasion | 27 (8.7) | 24 (12.0) | 0.222 | 25 (12.5) | 24 (12.0) | 0.879 |
| Tumor grade | ||||||
| Well/moderately | 258 (83.0) | 156 (78.0) | 0.163 | 166 (83.0) | 156 (78.0) | 0.207 |
| Poorly | 53 (17.0) | 44 (22.0) | 34 (17.0) | 44 (22.0) | ||
| Positive resection margin | 11 (3.5) | 13 (6.5) | 0.122 | 9 (4.5) | 13 (6.5) | 0.380 |
| TNM stage | ||||||
| I/II | 218 (70.1) | 113 (56.5) | 0.002 | 124 (62.0) | 113 (56.5) | 0.263 |
| III | 93 (29.9) | 87 (43.5) | 76 (38.0) | 7 (43.5) | ||
| Adjuvant therapy | 146 (46.9) | 72 (36.0) | 0.015 | 74 (37.0) | 72 (36.0) | 0.835 |
Categorical variables were expressed as n (%); continuous variables are expressed as medians and interquartile ranges (IQR).
PSM, propensity score matching; ASA, American Society of Anesthesiologists; CA19-9, carbohydrate antigen 19-9; CA125, carbohydrate antigen 125.
The relationships between preoperative nutritional status and postoperative short outcomes in 511 patients who underwent pancreatoduodenectomy for ampullary carcinoma after PSM.
| Variables | Total | Before PSM | After PSM | ||||
|---|---|---|---|---|---|---|---|
| Well-nourished/moderately malnourished | Severely malnourished | p-value | Well-nourished/moderately malnourished | Severely malnourished | p-value | ||
| N = 511 | N = 311 | N = 200 | N = 200 | N = 200 | |||
| Overall postoperative complications | 187 (36.6) | 86 (27.7) | 101 (50.5) | <0.001 | 65 (32.5) | 101 (50.5) | <0.001 |
| Postoperative complications (CD≥IIIa) | 98 (19.2) | 42 (13.5) | 56 (28.0) | <0.001 | 32 (16.0) | 56 (28.0) | 0.004 |
| Pancreatic fistula | |||||||
| Grade A | 61 (11.9) | 35 (11.3) | 26 (13.0) | 0.005 | 25 (12.5) | 26 (13.0) | 0.06 |
| Grade B | 27 (5.3) | 8 (2.6) | 19 (9.5) | 6 (3.0) | 19 (9.5) | ||
| Grade C | 4 (0.8) | 2 (0.6) | 2 (1.0) | 2 (1.0) | 2 (1.0) | ||
| Bile leakage | 9 (1.8) | 5 (1.6) | 4 (2.0) | 0.742 | 5 (2.5) | 4 (2.0) | 0.736 |
| Postoperative hemorrhage | 46 (9.0) | 18 (5.8) | 28 (14.0) | 0.002 | 15 (7.5) | 28 (14.0) | 0.053 |
| Delayed gastric emptying | |||||||
| Grade A | 77 (15.1) | 30 (9.6) | 47 (23.5) | <0.001 | 23 (11.5) | 47 (23.5) | 0.006 |
| Grade B | 18 (3.5) | 9 (2.9) | 9 (4.5) | 8 (4.0) | 9 (4.5) | ||
| Grade C | 6 (1.2) | 2 (0.6) | 4 (2.0) | 1 (0.5) | 4 (2.0) | ||
| Intra-abdominal abscess | 46 (9.0) | 25 (8.0) | 21 (10.5) | 0.343 | 18 (9.0) | 21 (10.5) | 0.613 |
| Mortality | 20 (3.9) | 7 (2.3) | 13 (6.5) | 0.016 | 7 (3.5) | 13 (6.5) | 0.169 |
| Postoperative hospital stay, days | 21 (16–27) | 20 (15–27) | 22 (18–27) | 0.047 | 20 (15–27) | 22 (18–27) | 0.149 |
Categorical variables were expressed as n (%); continuous variables are expressed as medians and interquartile ranges (IQR).
PSM, propensity score matching; CD, Clavien–Dindo classification.
Figure 3Overall survival curves for patients in the well-nourished group, moderately malnourished group, and severely malnourished group before and at 3, 6, and 12 months after pancreatoduodenectomy. (A–D) Significant overall survival difference were observed among the three groups (p < 0.001).
Univariate and multivariate Cox proportional hazard regression analysis of prognostic factors for OS in patients who underwent pancreatoduodenectomy for ampullary carcinoma after PSM.
| Factors | No. Patients | Univariate analysis | Multivariate analysis | ||||
|---|---|---|---|---|---|---|---|
| HR (95%CI) | P | HR (95%CI) | P | ||||
| Age (>65 years vs. ≤65 years) | 80/320 | 1.474 (1.098–1.978) | 0.01 | ||||
| Sex (male vs. female) | 235/165 | 0.928 (0.720–1.196) | 0.564 | ||||
| Comorbidities (+ vs. −) | 96/304 | 1.010 (0.754–1.353) | 0.948 | ||||
| BMI (>25 kg/m2 vs. ≤25 kg/m2) | 47/353 | 1.013 (0.683–1.501) | 0.950 | ||||
| ASA class (III vs. I or II) | 55/345 | 1.387 (0.981–1.961) | 0.064 | ||||
| T stage (T3/T4 vs. T1/T2) | 206/194 | 1.831 (1.418–2.365) | <0.001 | ||||
| Lymph node metastasis (+ vs. −) | 148/252 | 2.054 (1.595–2.647) | <0.001 | ||||
| Vascular invasion (+ vs. −) | 31/369 | 1.903 (1.238–2.926) | 0.003 | ||||
| Perineural invasion (+ vs. −) | 49/351 | 1.857 (1.299–2.655) | 0.001 | 1.958 (1.307–2.934) | 0.001 | ||
| Tumor grade (poorly vs. moderately or well) | 78/322 | 3.115 (2.316–4.190) | <0.001 | 2.280 (1.568–3.314) | <0.001 | ||
| Resection margins (+ vs. −) | 22/378 | 3.163 (1.985–5.042) | <0.001 | 2.768 (1.504–5.093) | 0.001 | ||
| TNM stage (III vs. I or II) | 163/237 | 2.290 (1.776–2.954) | <0.001 | 1.575 (1.123–2.209) | 0.008 | ||
| Adjuvant therapy (+ vs. −) | 146/254 | 0.588 (0.449–0.769) | <0.001 | 0.712 (0.520–0.976) | 0.035 | ||
| PG-SGA score | |||||||
| Before operation (>9 vs. <9 scores) | 200/200 | 1.840 (1.429–2.369) | <0.001 | 1.508 (1.103–2.061) | 0.01 | ||
| At 3 months after operation (>9 vs. <9 scores) | 67/420 | 2.996 (2.146–4.183) | <0.001 | ||||
| At 6 months after operation (>9 vs. <9 scores) | 68/406 | 13.754 (9.449–19.995) | <0.001 | 4.148 (2.523–6.820) | <0.001 | ||
| At 12 months after operation (>9 vs. <9 scores) | 116/323 | 8.680 (6.314–11.931) | <0.001 | 5.272 (3.630–7.656) | <0.001 | ||
OS, overall survival; PSM, propensity score matching; BMI, body mass index; ASA, American Society of Anesthesiologists; PG-SGA, Patient-Generated Subjective Global Assessment.